Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001140361-24-048416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-04 | 2024-12-02 | ANGO | Weiss Lawrence T | SVP, CLO | A - Grant | $0.00 | +52.7K | 52.7K | New | $0 |
| D | 2024-12-04 | 2024-12-02 | ANGO | Weiss Lawrence T | SVP, CLO | A - Grant | $0.00 | +103.7K | 103.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | A | A | 52,697 | $0.00 | 52,697 | D | — | — | (F1) The acquisition of 52,697 shares of common stock ("Common Stock") of AngioDynamics, Inc.("AngioDynamics") represents 52,697 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on December 2, 2025, such that 25% of the restricted stock units will vest on each of December 2, 2025, 2026, 2027 and 2028. |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-12-02 | A | A | 103,650 | $0.00 | 103,650 | D | $7.14 · 2025-12-02 to 2034-12-02 | 103,650 Common Stock | (F2) These stock options vest in four equal annual installments beginning on December 2, 2025, such that 25% of the options will vest on each of December 2, 2025, 2026, 2027 and 2028. |